pyrroles has been researched along with Esophagitis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 8 (53.33) | 2.80 |
| Authors | Studies |
|---|---|
| Facius, A; Howden, CW; Lahu, G; Leifke, E; Mulford, DJ; Scarpignato, C; Smith, N | 1 |
| Deguchi, H; Fernandez, J; Fujimori, I; Igarashi, A; Nakano, H; Oshima, T | 1 |
| DeVault, K; Hunt, B; Katz, P; Laine, L; Lowe, J; Mitev, S; Spechler, S | 1 |
| Facius, A; Howden, CW; Hunt, R; Lahu, G; Leifke, E; Mulford, DJ; Scarpignato, C | 1 |
| Cash, BD; Merchant, A; Ramani, A | 1 |
| Adler, DG; Bapaye, J; Chandan, OC; Chandan, S; Deliwala, S; Dhindsa, B; Facciorusso, A; Kassab, LL; Mohan, BP; Ramai, D | 1 |
| Miwa, H; Oshima, T | 1 |
| Fukuhara, T; Furukawa, Y; Hatsushika, Y; Kohno, T; Miyaki, E; Mori, N; Mouri, R; Ochi, H; Okanobu, H; Okazaki, A; Sakano, A; Takaki, S; Tsuji, K; Urabe, A; Yamashita, Y | 1 |
| Arai, E; Fukui, H; Kondo, T; Miwa, H; Oshima, T; Taki, M; Tomita, T; Watari, J | 1 |
| Flores, RM; Kanth, R; Shah, MS | 1 |
| Ashida, K; Chiba, T; Hiramatsu, N; Iwakiri, K; Kudou, K; Nishimura, A; Sakurai, Y; Umegaki, E | 1 |
| Ashida, K; Hiramatsu, N; Hori, T; Iwakiri, K; Kudou, K; Nishimura, A; Sakurai, Y; Umegaki, E | 1 |
| Bories, E; Caillol, F; Giovannini, M; Gravis, G; Jeanniard-Malet, O; Pesenti, C | 1 |
| Huang, J; Huang, Y; Wang, T | 1 |
| Bonomi, L; Imarisio, I; Paglino, C; Porta, C | 1 |
4 review(s) available for pyrroles and Esophagitis
| Article | Year |
|---|---|
Network Meta-analysis Comparing Vonoprazan and Proton Pump Inhibitors for Heartburn Symptoms in Erosive Esophagitis.
Topics: Adult; Bayes Theorem; Esophagitis; Gastroesophageal Reflux; Heartburn; Humans; Network Meta-Analysis; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Randomized Controlled Trials as Topic; Sulfonamides; Treatment Outcome | 2022 |
Review of the clinical development of fexuprazan for gastroesophageal reflux-related disease.
Topics: Esophagitis; Gastroesophageal Reflux; Humans; Peptic Ulcer; Proton Pump Inhibitors; Pyrroles | 2023 |
Vonoprazan versus lansoprazole in erosive esophagitis - A systematic review and meta-analysis of randomized controlled trials.
Topics: Esophagitis; Humans; Lansoprazole; Peptic Ulcer; Proton Pump Inhibitors; Pyrroles; Randomized Controlled Trials as Topic | 2023 |
Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib.
Topics: Acneiform Eruptions; Antineoplastic Agents; Benzenesulfonates; Erythema; Esophagitis; Exanthema; Humans; Hypertension; Indoles; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib | 2007 |
5 trial(s) available for pyrroles and Esophagitis
| Article | Year |
|---|---|
Vonoprazan Versus Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial.
Topics: Adult; Esophagitis; Humans; Lansoprazole; Peptic Ulcer; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2023 |
Efficacy of vonoprazan 10 mg compared with 20 mg for the initial treatment in patients with erosive esophagitis: a randomized pilot study.
Topics: Esophagitis; Humans; Pilot Projects; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2021 |
Randomised clinical trial: vonoprazan versus lansoprazole for the initial relief of heartburn in patients with erosive oesophagitis.
Topics: Adult; Aged; Double-Blind Method; Esophagitis; Female; Gastroesophageal Reflux; Heartburn; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2019 |
Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Esophagitis; Female; Gastrins; Humans; Lansoprazole; Los Angeles; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2015 |
Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis.
Topics: Adult; Aged; Cytochrome P-450 CYP2C19; Double-Blind Method; Esophagitis; Female; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Recurrence; Sulfonamides; Wound Healing | 2016 |
6 other study(ies) available for pyrroles and Esophagitis
| Article | Year |
|---|---|
A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race, Disease Status, and Other Covariates on Exposure.
Topics: Esophagitis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2022 |
A translational pharmacokinetic/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and Helicobacter pylori infection.
Topics: Esophagitis; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Proton Pump Inhibitors; Pyrroles | 2023 |
How Does Vonoprazan Affect the Treatment of Erosive Esophagitis?
Topics: Esophagitis; Gastroesophageal Reflux; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2021 |
Statin-associated polymyositis following omeprazole treatment.
Topics: Anticholesteremic Agents; Atorvastatin; Drug Interactions; Esophagitis; Gemfibrozil; Heptanoic Acids; Humans; Male; Methotrexate; Middle Aged; Myocardial Infarction; Omeprazole; Polymyositis; Prednisone; Proton Pump Inhibitors; Pyrroles; Treatment Outcome; Withholding Treatment | 2013 |
Three cases of severe ulcerative esophagitis induced by SUTENT®.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Esophagitis; Gastrointestinal Hemorrhage; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Prostatic Neoplasms; Pyrroles; Sunitinib; Ulcer | 2012 |
Exfoliative esophagitis in a patient with metastatic renal cell carcinoma during sunitinib treatment.
Topics: Amlodipine; Antihypertensive Agents; Antineoplastic Agents; Aspirin; Carcinoma, Renal Cell; Cyclooxygenase 2 Inhibitors; Esophagitis; Humans; Hypertension; Indoles; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Nephrectomy; Pyrroles; Sunitinib; Tetrazoles; Valine; Valsartan | 2013 |